Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1997-11-19
|
pubmed:abstractText |
We retrospectively evaluated antiinfective therapy for methicillin-sensitive (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) endocarditis in 54 patients who had 57 treatment courses for the disease. Three treatments were assessed: 27 nafcillin-treated courses of MSSA endocarditis, 18 vancomycin-treated courses of MSSA endocarditis, and 11 vancomycin-treated courses of MRSA endocarditis. At baseline, patients with MSSA treated with vancomycin had more chronic conditions (p<0.01), a lower frequency of intravenous drug use (p<0.01), a lower hematocrit concentration (p<0.05), and a higher serum creatinine concentration (p<0.05) than the nafcillin group. Vancomycin-treated patients had a higher complication rate during therapy (p<0.05) and a longer duration in an intensive care unit (p<0.01) than the nafcillin group. The trend was for a higher complete response rate in the nafcillin group (74% vs 50%, p=0.12), but no difference in mortality (22% vs 28%, p=0.73). Patients with MRSA infection treated with vancomycin had higher mortality than those with MSSA who received that drug (55% vs 28%, p=0.24). Patients with vancomycin-treated MSSA endocarditis may have a poorer outcome than those who receive nafcillin, but this may be influenced by different or more severe clinical features.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0277-0008
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
990-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9324187-Adult,
pubmed-meshheading:9324187-Anti-Bacterial Agents,
pubmed-meshheading:9324187-Endocarditis, Bacterial,
pubmed-meshheading:9324187-Female,
pubmed-meshheading:9324187-Humans,
pubmed-meshheading:9324187-Male,
pubmed-meshheading:9324187-Methicillin Resistance,
pubmed-meshheading:9324187-Middle Aged,
pubmed-meshheading:9324187-Nafcillin,
pubmed-meshheading:9324187-Retrospective Studies,
pubmed-meshheading:9324187-Staphylococcal Infections,
pubmed-meshheading:9324187-Treatment Outcome,
pubmed-meshheading:9324187-Vancomycin
|
pubmed:articleTitle |
Retrospective evaluation of therapies for Staphylococcus aureus endocarditis.
|
pubmed:affiliation |
Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 60612, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|